Universal Display Corp. 10-Q Summary
Business Context and Reporting Period
Universal Display Corporation (Universal Display) is engaged in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials. The company primarily licenses its proprietary technologies to product manufacturers and sells OLED materials. This report covers the quarterly period ended June 30, 2010.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2010 | Six Months Ended June 30, 2010 |
|---|---|---|
| Total Revenue | $8,446,829 | $12,693,479 |
| Net Loss | $(4,436,095) | $(7,414,426) |
| Net Loss Per Share (Basic/Diluted) | $(0.12) | $(0.20) |
| Operating Loss | $(1,909,144) | $(6,133,476) |
| Cash and Cash Equivalents | $11,754,285 | $11,754,285 |
| Short-Term Investments | $54,338,639 | $54,338,639 |
| Total Liquidity | $66,092,924 | $66,092,924 |
| Accumulated Deficit | $(204,523,131) | $(204,523,131) |
Debt and Liabilities: The company reported no long-term debt. Total liabilities were $25,521,611, including a significant Stock Warrant Liability of $5,589,350 and a Retirement Plan Benefit Liability of $5,807,038.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased significantly compared to the prior year periods. For the three months ended June 30, 2010, revenue rose to $8.45 million from $2.96 million in 2009. For the six months, revenue increased to $12.69 million from $5.79 million in 2009.
- Revenue Composition: The increase was driven by a $2.1 million recognition of technology development revenue (previously deferred) and increased sales of development chemicals. Commercial revenue also grew due to royalties from Samsung SMD and license fees from Showa Denko.
- Operating Loss Improvement: Operating loss narrowed to $1.91 million for the quarter (from $6.31 million in 2009) and $6.13 million for the six months (from $12.30 million in 2009), primarily due to revenue growth outpacing expense increases.
- Non-Cash Losses: Net loss was impacted by a non-cash loss on stock warrant liability of $2.58 million for the quarter and $1.87 million for the six months, compared to $0.29 million and $0.12 million in the respective prior year periods.
- Cash Flow: Net cash used in operating activities decreased to $2.76 million for the six months ended June 30, 2010, compared to $8.80 million in the prior year period.
Guidance, Outlook, and Risks
- Liquidity Outlook: Management anticipates sufficient cash, cash equivalents, and short-term investments to meet obligations for at least the next 12 months. Total liquidity stands at approximately $66.1 million.
- Future Funding: While current resources are adequate, the company notes that additional funding may be required in the future for R&D, patent enforcement, and working capital. There is no assurance that such funds will be available on commercially reasonable terms.
- Legal Proceedings (Patent Oppositions): The company is facing multiple patent challenges:
- European Patent No. 0946958: CDT (Sumitomo) appealed an EPO decision upholding the patent. The company expects to file a reply by August 12, 2010.
- European Patent No. 1449238: Oppositions filed by Sumation, Merck, and BASF are pending an oral hearing.
- European Patent No. 1394870: Five European companies (including Merck, BASF, Osram, Siemens, and Philips) filed oppositions. A response is due October 4, 2010.
- Japanese Patents: Invalidation trials filed by Semiconductor Energy Laboratory (SEL) for three Japanese patents are pending responses.
- Retirement Plan: The company adopted a Supplemental Executive Retirement Plan (SERP) effective April 1, 2010, resulting in a $5.6 million prior service cost recorded as accumulated other comprehensive loss.
Key Facts for Investor Verification
- Revenue Recognition Timing: Verify the sustainability of the $2.1 million technology development revenue recognized in Q2 2010, which relates to payments received between 2001 and 2006 that were previously deferred.
- Stock Warrant Liability Volatility: Monitor the fair value of the $5.6 million stock warrant liability, which is sensitive to stock price and volatility and creates significant non-cash losses.
- Patent Defense Costs: Assess the potential financial impact of ongoing patent oppositions in Europe and Japan, as the company is contractually obligated to pay all legal costs associated with these proceedings.
- Customer Concentration: Note that three non-government customers accounted for approximately 69% of revenue in the quarter, and 84% of revenue was derived from outside North America.
- Single Supplier Risk: Confirm the stability of the supply chain, as all chemical materials sold by the company are purchased from a single supplier (PPG Industries).